Amplified Sciences has a test available in our CLIA lab to assist clinicians in the risk stratification of patients diagnosed with pancreatic cystic lesions (PCL). The PanCystPro test will allow clinicians to define low risk and/or benign pancreatic cysts, ruling out potential for malignancy thus resulting in patients’ peace of mind.
Only doctors can order this test so ask your doctor if they perform the test before you undergo any fine needle biopsy (FNA) procedures to sample your pancreatic cystic lesions.
If you have questions about pancreatic cancer, the links below will bring you to several informative websites that can assist you with your patient journey.
